Dr. Reddy's Laboratories Limited - ADR (RDY) Earnings

RDY Earnings Reports

Positive Surprise Ratio

RDY beat 24 of 43 last estimates.

56%

Next Report

Date of Next Report

Jan 19, 2027

Estimate for Q3 27 (Revenue/ EPS)

$88.52B

$12.06

Implied change from Q2 27 (Revenue/ EPS)

+2.99%

+5.88%

Implied change from Q3 26 (Revenue/ EPS)

+1.13%

-16.94%

Dr. Reddy's Laboratories Limited - ADR earnings per share and revenue

On Oct 23, 2026, RDY reported earnings of 11.39 USD per share (EPS) for Q2 27, beating the estimate of 9.34 USD, resulting in a 21.93% surprise. Revenue reached 85.96 billion, compared to an expected 86.42 billion, with a -0.53% difference.

Looking ahead to Q3 27, -- analysts forecast an EPS of 12.06 USD, with revenue projected to reach 88.52 billion USD, implying an increase of 5.88% EPS, and increase of 2.99% in Revenue from the last quarter.

FAQ

What were Dr. Reddy's Laboratories Limited - ADR's earnings and revenue for the latest quarter Q2 2027?

For Q2 2027, Dr. Reddy's Laboratories Limited - ADR reported EPS of $11.39, beating estimates by 21.93%, and revenue of $85.96B, -0.53% below expectations.

How did the market react to Dr. Reddy's Laboratories Limited - ADR's Q2 2027 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Dr. Reddy's Laboratories Limited - ADR expected to report next?

The next earning report is scheduled for Jan 19, 2027.

What are the forecasts for Dr. Reddy's Laboratories Limited - ADR's next earnings report?

Based on -- analysts, Dr. Reddy's Laboratories Limited - ADR is expected to report EPS of $12.06 and revenue of $88.52B for Q3 2027.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.